F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
D

Failure to Inform Resident of Medication Change

Crestwood Care CenterShelby, Ohio Survey Completed on 09-25-2024

Summary

The facility failed to timely inform and allow Resident #100 to participate in their treatment, specifically regarding the discontinuation of Oxycodone HCL, a pain medication. Resident #100, who had intact cognition and was suffering from osteoarthritis and chronic pain syndrome, was not notified of the discontinuation of her Oxycodone medication until four days after it was stopped. During this period, the resident experienced severe pain, with levels ranging from six to ten on the pain scale, and was not provided with effective alternative pain management solutions. The medical records and interviews revealed that Resident #100 spent several days in significant distress, experiencing symptoms such as shaking, anxiety, and excruciating pain, which were not alleviated by the alternative medication, Percocet, or other interventions. Despite the resident's and her family's repeated requests for the reinstatement of Oxycodone, the facility's physician did not provide any alternative pain management until the resident's son intervened. The facility's staff, including LPN #3, confirmed that they had informed the physician of the resident's severe pain and withdrawal symptoms, but no action was taken until the family got involved. The facility's policies on pain management and notification of changes in condition were not adhered to, as Resident #100 was not informed of the medication change, nor was she involved in the decision-making process. The Director of Nursing confirmed that the resident and her family were not present during the meeting where the decision to discontinue Oxycodone was made, and there was no documentation of notification to the resident. This deficiency was investigated under Complaint Number OH00157343.

Penalty

Inspection fine: $39,130
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Resources

Below are regulatory guidelines relevant to this citation:

See other F0552 citations
Failure to Obtain Informed Consent Before Starting Duloxetine
D
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

Failure to Obtain Informed Consent Before Starting Duloxetine: The facility failed to obtain and document informed consent before starting Duloxetine for a resident with anxiety, depression, and chronic pain. The DON confirmed there was no informed consent for the medication, and the facility policy required informed consent before initiating psychotropic meds, including discussion of the target symptom, intended benefit, risks/side effects, and alternatives.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Failure to Obtain Informed Consent for Psychotropic Medications
D
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

Failure to Obtain Informed Consent for Psychotropic Medications: Two residents receiving psychotropic medications, including antidepressants, antipsychotics, and mood stabilizers, did not have documented informed consent in their records before the medications were administered. One resident had diagnoses including depression, bipolar disorder, and schizophrenia, and the other had traumatic brain injury, schizoaffective disorder-bipolar type, major depressive disorder, and paraplegia. The DON could not provide consent documentation for one resident, and the other resident's record lacked consent explaining the risks and benefits of the medications. The NP stated the facility is responsible for obtaining medication consents when residents are admitted on psychotropics or when doses or medications change.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Failure to Inform Resident/Representative Before Diazepam Use
D
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

A resident with diabetes, dementia, and CHF was started on Diazepam for anxiety, but the clinical record lacked evidence that the resident and/or representative were informed in advance of the medication’s risks, benefits, and alternative treatments. The DON confirmed the missing documentation, and the facility policy required RN-obtained consent and notification of the resident’s representative regarding desired effects and potential side effects.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Failure to Obtain Informed Consent for Psychotropic Medications
D
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

A resident with intact cognition and diagnoses including renal dialysis dependence, type 2 DM, and insomnia was prescribed clonazepam and temazepam, but the medical record lacked evidence of informed consent for either psychotropic medication. The DON was unable to locate signed consent, and stated that residents admitted on psychotropic meds needed a consent form signed on admission day.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Failure to Inform Residents of Nonpharmacological Options for Psychotropic Medications
E
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

The facility failed to document and offer nonpharmacological treatment options when obtaining consent for psychotropic medications for several residents. A resident with PTSD, anxiety, and depression; a resident with severe cognitive impairment and dementia; and two residents with dementia-related behaviors received antipsychotic, antianxiety, and/or antidepressant medications, and consent forms were completed, but the records did not show that alternate treatment interventions were presented. The DON confirmed the facility had no evidence that these options were provided with the psychotropic medication consents.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Failure to Obtain Informed Consent for Psychotropic Medications
D
F0552 F552: Ensure that residents are fully informed and understand their health status, care and treatments.
Short Summary

Failure to obtain informed consent for psychotropic medications: two residents were prescribed medications for mental health-related conditions, but the EMR did not show education or consent for all ordered drugs. One resident with intact cognition had orders for Depakote and gabapentin without documented education on risks, benefits, side effects, or alternatives. Another resident with severe cognitive impairment had consent for Celexa, but not for hydroxyzine or risperidone; the DON stated residents and/or families should know the risks and side effects before deciding to take the medication.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Citation search

Search every citation & Plan of Correction

Go to search
Citation watch

Track new serious citations across Ohio

Get a heads-up on the newest immediate-jeopardy (J–L) citations in Ohio — where surveyors are focused right now.

Free · about one email a month

Trusted data from CMS and state health departments

Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.

In your survey window? See what surveyors are citing.

The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.

Get the Survey-Prep Report
An unhandled error has occurred. Reload 🗙

Connection lost — reconnecting… We couldn't reconnect automatically. Please reload the page to continue.